Form 4: Guardant Health Director Tariq Musa Exercises Restricted Stock Units

Guardant Health, Inc. Director Tariq Musa acquired 250 shares of common stock through the exercise of Restricted Stock Units (RSUs) on July 15, 2025, increasing his direct beneficial ownership to 7,440 shares.

Summary

• Tariq Musa, a Director of Guardant Health, Inc. (GH), reported a transaction on July 15, 2025.
• The transaction involved the exercise of 250 Restricted Stock Units (RSUs) into 250 shares of Common Stock.
• The exercise price for both the RSUs and the underlying common stock was $0.
• Following this transaction, Tariq Musa's direct beneficial ownership of Common Stock increased to 7,440 shares.
• His direct beneficial ownership of Restricted Stock Units decreased to 4,997 units.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled event.
• The RSUs were granted on March 6, 2023, with 25% vesting on March 15, 2024, and the remaining 75% vesting monthly over the subsequent three-year period.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director increasing their direct ownership of common stock, albeit through the exercise of vested equity compensation. The transaction being pre-planned (10b5-1) adds to its routine and expected nature, preventing any strong negative or positive sentiment.

Positives

• The transaction represents an increase in direct common stock ownership by a company director, which can be viewed positively by investors as it aligns insider interests with shareholder interests.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled and transparent exercise of vested equity, rather than a discretionary sale or purchase based on immediate market conditions.

Future Outlook

The remaining 4,997 Restricted Stock Units held by Tariq Musa are subject to a vesting schedule where 75% of the original grant vests monthly over a three-year period following March 15, 2024.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies, reflecting a director's exercise of vested equity compensation. It does not provide broader industry trends or competitive insights.

Stakeholder Impact

• Shareholders: The increase in a director's direct common stock ownership may be viewed as a positive signal of alignment with shareholder interests.

Next Steps

• Continued monthly vesting of the remaining 4,997 Restricted Stock Units held by Tariq Musa over the next three years.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Director, Equity Compensation, Rule 10b5-1